In contrast, a significant relationship between methylation status and MGMT immunoexpression was not observed in the carcinoma and SS3 pituitary adenomas [12], and a methylated MGMT promoter did not tend to correlate with a response to TMZ exposure [5]. Here, MGMT is linked to carcinoma.